The president of Venezuela, Nicolás Maduro, reiterated on Sunday that his country acquired 10 million doses of the Vaccine Russian Sputnik V against Covid-19, which he said is the safest in the world.
« We have 10 million doses of Vaccine purchased that will be arriving in Venezuela from Sputnik V, which until now is the Vaccine safest in the world, « said the president during a speech.
In December, the Venezuelan Government signed an agreement with Russia for the acquisition of the Vaccine Sputnik.
« There are 10 million Vaccines for now, 20, 30, 40 million will come later, well a significant percentage has to be to cover the needs of ALBA (Bolivarian Alliance for the Peoples of Our America), it cannot be everyone on their own, « he said.
Maduro has said repeatedly that women are expected to Vaccines arrive in Venezuela in the first quarter of 2021, and that they estimate to start immunization, in a first stage, in the month of April.
Venezuela participates in phase 3 of the Sputnik V clinical trials, in which 2,000 people participate.
On the other hand, Maduro indicated that he wants to sign an agreement with Cuba for the acquisition of the Vaccine Sovereign 02 against him Coronavirus.
Regarding the daily report, Venezuela registered in the last 24 hours 424 cases of community transmission and 14 of people who have arrived from other countries, for a total of 438 infections.
To date, the Caribbean country has a total of 116,610, of which only 4,990 cases remain active.
Maduro indicated that his country will maintain the 7 + 7 method, which consists of seven days of easing the economy and then seven days of radical quarantine, to prevent the spread of the Covid-19.
In addition, he announced that his Government is studying a partial modality of returning to classes in person, because since last March school activities have been kept at a distance online.
Coronavirus in the world today: all the information
Coronavirus in Argentina: All the information about the pandemic throughout the country
Coronavirus vaccine: progress in the race to combat covid-19